Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
Apply
NVL-520
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step